» Articles » PMID: 33798555

IL-4Rα Signaling by CD8α Dendritic Cells Contributes to Cerebral Malaria by Enhancing Inflammatory, Th1, and Cytotoxic CD8 T Cell Responses

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2021 Apr 2
PMID 33798555
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Persistent high levels of proinflammatory and Th1 responses contribute to cerebral malaria (CM). Suppression of inflammatory responses and promotion of Th2 responses prevent pathogenesis. IL-4 commonly promotes Th2 responses and inhibits inflammatory and Th1 responses. Therefore, IL-4 is widely considered as a beneficial cytokine via its Th2-promoting role that is predicted to provide protection against severe malaria by inhibiting inflammatory responses. However, IL-4 may also induce inflammatory responses, as the result of IL-4 action depends on the timing and levels of its production and the tissue environment in which it is produced. Recently, we showed that dendritic cells (DCs) produce IL-4 early during malaria infection in response to a parasite protein and that this IL-4 response may contribute to severe malaria. However, the mechanism by which IL-4 produced by DCs contributing to lethal malaria is unknown. Using Plasmodium berghei ANKA-infected C57BL/6 mice, a CM model, we show here that mice lacking IL-4Rα only in CD8α DCs are protected against CM pathogenesis and survive, whereas WT mice develop CM and die. Compared with WT mice, mice lacking IL-4Rα in CD11c or CD8α DCs showed reduced inflammatory responses leading to decreased Th1 and cytotoxic CD8 T cell responses, lower infiltration of CD8 T cells to the brain, and negligible brain pathology. The novel results presented here reveal a paradoxical role of IL-4Rα signaling in CM pathogenesis that promotes CD8α DC-mediated inflammatory responses that generate damaging Th1 and cytotoxic CD8 T cell responses.

Citing Articles

Interleukin-4 and its receptor alpha in paediatric uncomplicated malaria patients from a Ghanaian case-control study.

Diaba-Nuhoho P BMC Res Notes. 2024; 17(1):328.

PMID: 39482779 PMC: 11529267. DOI: 10.1186/s13104-024-06984-5.


A Head-to-Head Comparative Study of the Replication-Competent Vaccinia Virus and AAV1-Based Malaria Vaccine versus RTS,S/AS01 in Murine Models.

Zainal K, Hasyim A, Yamamoto Y, Mizuno T, Sato Y, Rasyid S Vaccines (Basel). 2024; 12(10).

PMID: 39460322 PMC: 11512279. DOI: 10.3390/vaccines12101155.


Cytokine gene polymorphisms implicated in the pathogenesis of infection outcome.

Segbefia S, Asandem D, Amoah L, Kusi K Front Immunol. 2024; 15:1285411.

PMID: 38404582 PMC: 10884311. DOI: 10.3389/fimmu.2024.1285411.


Potential Benefits of Lycopene Consumption: Rationale for Using It as an Adjuvant Treatment for Malaria Patients and in Several Diseases.

Varela E, Gomes A, Santos A, de Carvalho E, Vale V, Percario S Nutrients. 2022; 14(24).

PMID: 36558462 PMC: 9787606. DOI: 10.3390/nu14245303.


Cerebral Malaria: Current Clinical and Immunological Aspects.

Albrecht-Schgoer K, Lackner P, Schmutzhard E, Baier G Front Immunol. 2022; 13:863568.

PMID: 35514965 PMC: 9067128. DOI: 10.3389/fimmu.2022.863568.


References
1.
Ghazanfari N, Mueller S, Heath W . Cerebral Malaria in Mouse and Man. Front Immunol. 2018; 9:2016. PMC: 6139318. DOI: 10.3389/fimmu.2018.02016. View

2.
Deroost K, Pham T, Opdenakker G, Van den Steen P . The immunological balance between host and parasite in malaria. FEMS Microbiol Rev. 2015; 40(2):208-57. DOI: 10.1093/femsre/fuv046. View

3.
Guenova E, Volz T, Sauer K, Kaesler S, Muller M, Wolbing F . IL-4-mediated fine tuning of IL-12p70 production by human DC. Eur J Immunol. 2008; 38(11):3138-49. DOI: 10.1002/eji.200838463. View

4.
Wu X, Dayanand K, Thylur R, Norbury C, Gowda D . Small molecule-based inhibition of MEK1/2 proteins dampens inflammatory responses to malaria, reduces parasite load, and mitigates pathogenic outcomes. J Biol Chem. 2017; 292(33):13615-13634. PMC: 5566520. DOI: 10.1074/jbc.M116.770313. View

5.
Hunt N, Grau G . Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003; 24(9):491-9. DOI: 10.1016/s1471-4906(03)00229-1. View